Wealth Enhancement Advisory Services’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$372K Buy
22,030
+1,955
+10% +$31.2K ﹤0.01% 3123
2026
Q2
$325K Buy
20,075
+1,477
+8% +$18.9K ﹤0.01% 3123
2026
Q1
$163K Buy
18,598
+4,158
+29% +$37.6K ﹤0.01% 3205
2025
Q4
$145K Sell
14,440
-1,341
-8% -$12.7K ﹤0.01% 3357
2025
Q3
$155K Sell
15,781
-340
-2% -$2.86K ﹤0.01% 3223
2025
Q2
$123K Buy
+16,121
New +$100K ﹤0.01% 3100

Other funds holding CYRX

Wealth Enhancement Advisory Services's CYRX Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its CryoPort (CYRX) stake by 9.7% in Q3 2026, buying an estimated $31.2K and bringing the position to 22,030 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #3123.

Wealth Enhancement Advisory Services first reported a position in CYRX in Q2 2025 and has held it in 6 quarters since. 195 funds tracked by Wall St. Rank hold CYRX as of Q3 2026.

  • Wealth Enhancement Advisory Services held 22,030 shares of CryoPort worth $372K as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 1,955 CryoPort shares in Q3 2026, an estimated $31.2K.
  • CryoPort made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3123 holding.
  • Wealth Enhancement Advisory Services first reported a position in CryoPort in Q2 2025 and has held it in 6 quarters since.
  • 195 funds tracked by Wall St. Rank held CryoPort as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.